INTRODUCTION
Inositol 1,4,5-trisphosphate [Ins (1, 4, 5) P $ ] 3-kinases are enzymes which catalyse the phosphorylation of Ins(1,4,5)P $ to Ins(1,3,4,5)P % , both potential modulators of calcium homoeostasis [1, 2] . Data presented by Irvine and colleagues [3, 4] indicated that Ins(1,3,4,5)P % binds to a protein of the GTPase-activating protein-1 (' GAP1 ') family and thereby modulates Ca# + mobilization by Ins(1,4,5)P $ . Another indication of a key regulatory role for the Ins(1,4,5)P $ 3-kinase(s) comes from recent data indicating that Ins(1,3,4,5)P % controls the frequency of calcium oscillations in HeLa cells [5] . cDNAs encoding two inositol trisphosphate 3-kinase isoenzymes have been reported to be present in rat and in human [referred to as Ins(1,4,5)P $ 3-kinases A and B] and these have been expressed in bacteria and in COS-7 cells [6] [7] [8] [9] [10] . Ins(1,4,5)P $ 3-kinase A was shown to be expressed at high levels in hippocampal CA1 pyramidal and in Purkinje cells [11] . Recent data obtained in our laboratory [12] have shown that Ins(1,4,5)P $ 3-kinase B is expressed in astrocytes and is phosphorylated in response to purinergic agonists.
In general, Ca# + in a complex with calmodulin stimulates mammalian Ins(1,4,5)P $ 3-kinase activity, despite the presence of proteolytic fragments often present during extraction and purification of the enzyme [13, 14] . This stimulating effect was attributed to the presence of a calmodulin-binding domain at the N-terminal end of the protein [15] . However, there is considerable cell-to-cell variability in the sensitivity of Ins(1,4,5)P $ 3-kinase activity to Ca# + -calmodulin activation. This could result from the existence of different isoforms and\or splice variants of a single gene. This difference in sensitivity to Ca# + was also shown for the two previously reported Ins(1,4,5)P $ 3-kinase A and B isoforms when expressed in Escherichia coli : the A isoform was stimulated 2-to 3-fold by Ca# + -calmodulin, whereas the B Abbreviation used : EST, expressed sequence tag. 1 To whom correspondence should be addressed (e-mail cerneux!ulb.ac.be).
transfected COS-7 cells. This inhibitory effect is reversed in the presence of calmodulin. The recombinant bacterial 3-kinase C can be adsorbed on calmodulin-Sepharose in the presence of calcium. The present data show that Ins(1,4,5)P $ 3-kinase C : (i) shares a conserved catalytic domain of about 275 amino acids with the two other mammalian isoforms, (ii) could be purified on a calmodulin-Sepharose column and (iii) could be distinguished from the A and B isoenzymes by the effects of calcium and of calmodulin.
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isoform was stimulated up to 10-fold [8, 9, 16] . The specificity of Ins(1,4,5)P $ phosphorylation by recombinant Ins(1,4,5)P $ 3-kinases A and B at the 3-position of the inositol ring has been resolved by HPLC [17] [18] [19] .
Recently, a new family of inositol polyphosphate kinases has been reported and several cDNAs encoding these enzymes have been cloned ; three of them (KIAA0263, PiUS and KCS1) are inositol hexakisphosphate (InsP ' ) kinases [20, 21] , and ArgRIII (also known as Arg82) was shown to be a multifunctional kinase (IPMK) which phosphorylates Ins(1,4,5)P $ and Ins(1,4,5,6)P % in Saccharomyces cere isiae [22] . In itro, ArgRIII catalyses the phosphorylation of Ins(1,4,5)P $ at both the 3-and 6-position of the inositol ring, forming Ins(1,3,4,5)P % and Ins(1,4,5,6)P % [23] . A role of this multikinase in nuclear mRNA export was recently described [23, 24] . In S. pombe, InsP ' is also synthesized from Ins(1,4,5)P $ and plays a role in osmotic regulation [25] . None of these enzymes appears to specifically produce Ins(1,3,4,5)P % , as is shown for the A and B forms of mammalian Ins(1,4,5)P $ 3-kinases. In mammalian systems, no phosphorylation at the 6-position [which would form Ins(1,4,5,6)P % ] has ever been observed.
There is speculation in the literature that the family of Ins(1,4,5)P $ 3-kinases may be more diverse. In human platelets, rat thymus and thyroid cells, the Ins(1,4,5)P $ 3-kinase appears to run on SDS\polyacrylamide gels as higher-molecular-mass protein(s) when compared with Ins(1,4,5)P $ 3-kinases A and B [26] [27] [28] . In the present paper, we report the sequence and expression of a third mammalian Ins(1,4,5)P $ 3-kinase (3-kinase C), which demonstrates enzymic activity when expressed in E. coli or COS-7 cells. We have shown, for the first time, inhibition of activity by calcium when measured in transfected COS-7 cells, suggesting a different mode of Ins(1,3,4,5)P % production in intact cells when compared with cells expressing the A and B isoforms. 
MATERIALS AND METHODS

Materials
Molecular cloning of human Ins(1,4,5)P 3 3-kinase C
A human thyroid cDNA library in λgt11 vector (Clontech) was screened using a mixture of two probes encoding human Ins(1,4,5)P $ 3-kinase A and Ins(1,4,5)P $ 3-kinase B [9] . Approx. 5i10& clones were screened. The nitrocellulose filters were washed four times in 2iSSC (1iSSC l 0.15 M NaCl\0.015 M sodium citrate)\0.1 % (w\v) SDS for 10 min at room temperature and twice in 0.2iSSC\0.1 % SDS for 15 min at 60 mC. This resulted in the isolation of one clone (HTC3K3), which was used in a second screening to isolate HTC3K7. HTC3K3 was digested with SacII and BglII and HTC3K7 with BglII and EcoRI. The two fragments obtained were subcloned into the pBluescript vector. The β-galactosidase in-frame fusion product encoded a partial sequence of human Ins(1,4,5)P $ 3-kinase C, i.e. 585 amino acids of the coding region, which was designated 3KS ( Figure  1A ).
The cDNA of clone HTC3K7 was also digested with the restriction enzymes BglII and XhoI. This fragment was used to replace a BglII-XhoI fragment of clone HTC3K3 to yield clone HTC3K3h. The EST sequence (AL044962) encoding the 5h-end of the cDNA of Ins(1,4,5)P $ 3-kinase C (459 bp) was amplified with a 5h-primer containing a BamHI restriction site (underlined) : 5h-CGGGATCCGGCATGAGGCGCTGCC-3h, and a 3h-primer : 5h-ATCAGTCCAAAGGCCATC-3h. The DNA of clone HTC3K3h was digested with EcoRI and the EST\PCR product with BamHI and EcoRI. The fragments obtained were subcloned into two expression vectors : pTrc-His A and pcDNA3-His C. The new His-tagged constructs were referred to as VKC1, when expressed in E. coli (DH5αFh), and COS3KC when expressed in COS-7 cells ( Figure 1B ).
Generation of a C-terminal peptide antibody against human
Ins (1, 4, 5 )P 3 3-kinase C An immune serum was raised against the synthetic peptide of the C-terminal sequence of human Ins(1,4,5)P $ 3-kinase C (GNRED-GYLWGLDNMI) derived from amino acids 660-674 (see Figure  2 ). The peptide was conjugated to keyhole-limpet haemocyanin (approx. 10 mg of peptide\carrier) in the presence of glutaraldehyde [29] , diluted 2-fold (v\v) in Freund's complete adjuvant and injected into New Zealand rabbits. A booster dose of 0.5 mg of peptide\carrier in Freund's incomplete adjuvant (v\v) was given at 10 days and again at 20 days. Immunodetection of the enzyme expressed in DH5αFh bacteria and COS-7 cells with both the peptide antibody (dilution 1 : 100) and the anti-His ' monoclonal antibody (dilution 1 : 5000) was performed using the ECL2 method.
Expression of recombinant Ins(1,4,5)P 3 3-kinase C in DH5αFh bacteria
The full-length 683-amino-acid Ins(1,4,5)P $ 3-kinase C and the truncated construct of 585 amino acids were subcloned into pTrc-His A (VKC1) and pBluescript (3KS) expression vectors respectively. Both constructs were used to transform DH5αFh bacteria. An overnight culture (5 ml) was used to inoculate 500 ml of Luria-Bertani medium containing 50 µg\ml ampicillin. After 6 h incubation at 37 mC, the medium was diluted to a D '!! of 1, isopropyl β-thiogalactopyranoside was added to a final concentration of 1 mM and the incubation was continued for 3 h at 30 mC. The cells were harvested by centrifugation at 2500 g for Cloning of isoform C of inositol trisphosphate 3-kinase 15 min and were resuspended in 19 ml of lysis buffer [50 mM Tris\HCl (pH 8.0), 1 mM EDTA, 10 % (w\v) sucrose, 12 mM 2-mercaptoethanol, 5 µM leupeptin and 50 µg\ml Pefabloc]. The cells, on ice, were briefly sonicated, using a microtip, three times for 5 s. Triton X-100 was added to a final concentration of 1 %, and the mixture was incubated for 10 min at 4 mC. The lysed cells were harvested by centrifugation at 10 000 g for 10 min and 18 ml of the lysate was applied on to an 8 ml calmodulinSepharose column which had been equilibrated with 20 mM Tris\HCl (pH 7.5), 0.1 M NaCl, 0.2 mM CaCl # , 0.1 % (v\v) Triton X-100, 12 mM 2-mercaptoethanol, 5 µM leupeptin and 50 µg\ml Pefabloc. The lysate was diluted in 36 ml of the same buffer containing 2 mM CaCl # . The column was washed with buffer A [20 mM Tris\HCl (pH 7.5), 0.2 mM CaCl # , 0.4 M NaCl, 0.5 % (v\v) Triton X-100, 12 mM 2-mercaptoethanol, 5 µM leupeptin and 50 µg\ml Pefabloc] and then with the same buffer without Triton X-100. The adsorbed proteins were eluted with buffer B [20 mM Tris\HCl (pH 7.5), 2 mM EGTA, 0.4 M NaCl, 12 mM 2-mercaptoethanol, 5 µM leupeptin and 50 µg\ml Pefabloc] and then with the same buffer containing 0.2 % (w\v) SDS. Peak fractions of the last elution were identified by Western blotting and Ins(1,4,5)P $ 3-kinase assay [13] .
Expression of Ins(1,4,5)P 3 3-kinase C in COS-7 cells
The full-length coding region of Ins(1,4,5)P $ 3-kinase C was subcloned into the pcDNA3-His C expression vector. Ins(1,4,5)P $ 3-kinase C was transfected into COS-7 cells (COS3KC) using the FuGENE method of transfection. The cells were grown in a humidified atmosphere of 5 % CO # at 37 mC and maintained in Dulbecco's modified Eagle's medium supplemented with 1 % (w\v) sodium pyruvate, 2 % penicillin\streptomycin and 10 % (v\v) fetal-calf serum. After 48 h, transfected cells were harvested, pelleted by centrifugation and resuspended in 300 µl of lysis buffer [20 mM Tris\HCl (pH 8.0), 150 mM KCl, 1 % (v\v) Triton X-100, 10 % (w\v) sucrose, 12 mM 2-mercaptoethanol, 5 µM leupeptin, 50 µg\ml Pefabloc and 10 µg\ml calpain inhibitors I and II). The cells were homogenized by passage five times through a 26-gauge needle and immediately used for Western blotting analysis and enzymic assay. For the subcellular distribution of enzyme activity, the cell lysates were centrifuged at 80 000 g for 30 min at 4 mC and the pellet was resuspended to the same volume as that of the original homogenate.
Northern-blot analysis
A blot containing poly(A) + -rich RNA from a variety of human tissues was purchased from Clontech. The membrane was probed with a 430 bp PCR product corresponding to the last 143 amino acids of human Ins(1,4,5)P $ 3-kinase C. Prehybridization was performed in 50 % formamide, 5iSSPE (1iSSPE l 0.15M NaCl\10 mM sodium phosphate (pH 7.4)\1 mM EDTA), 5iDenhardt's solution, 0.3 % SDS, 0.25 µg\ml herring sperm DNA and 200 µg\ml BSA at 42 mC. The hybridation procedure was similar, except that 10 % dextran sulphate was added to the hybridization solution. The blot was washed three times for 10 min in 2iSSC\0.1 % SDS at room temperature and then three times for 30 min in 0.1iSSC\0.1 % SDS at 60 mC.
HPLC analysis
The purified, recombinant enzyme (VKC1) was incubated at 37 mC with trace amounts (10 000 
RESULTS AND DISCUSSION
Cloning of cDNAs encoding human Ins(1,4,5)P 3 3-kinase C
The presence of a 100 kDa Ins(1,4,5)P $ 3-kinase has been reported in FRTL-5 cells. In these thyroid cells, activity was stimulated approx. 2-fold after activation by thyroid stimulating hormone [28] . This high-molecular-mass enzyme, which was poorly stimulated by Ca# + , prompted us to screen a human thyroid cDNA library in order to search for new isoforms. Two cDNA clones encoding a novel Ins(1,4,5)P $ 3-kinase isoenzyme were isolated following this screening. These clones, referred to as HTC3K3 and HTC3K7 (GenBank accession number D38169, Figure 1) , encoded a new partial sequence, referred to as 3-kinase C, which was different from the A and B isoforms described in human and rat [6] [7] [8] [9] [10] . A BLAST search in the human EST database identified a sequence available at the RZPD (Berlin, Germany) that covered the 5h-end of the cDNA (accession number AL044962). These three overlapping clones encoded a 683-amino-acid protein [Ins(1,4,5)P $ 3-kinase C ; accession number AJ290975] with a calculated molecular mass of 75.207 kDa ( Figure 1B isoform (LDCK#'#). When the lysine residue (Lys#'#) in 3-kinase A was substituted with alanine, no Ins(1,4,5)P $ 3-kinase activity was detected [31] . This very conserved and catalytically essential lysine residue (Lys%)' in Figure 2 ), also present in the human 3-kinase A and B isoforms, was conserved in the different InsP ' kinases [21, 22] and in the yeast protein ArgRIII [24] . The sequence of Ins(1,4,5)P $ 3-kinase C also contained part of the ATP binding site described in 3-kinases A and B (Figure 2 , DFG motif in bold type) [32] . Six sites, which were potential sites of phosphorylation by protein kinase C, were found at amino acids 106-108, 119-121, 222-224, 249-251, 404-406 and 652-654 (Figure 2 , double-underlined residues). No calmodulin kinase II phosphorylation site was seen in the sequence, in contrast with that found in the A and B isoforms [12, 33] . Potential residues essential for calmodulin binding were identified after an align- Figure 4 Conserved residues between mammalian Ins (1, 4, 5 
)P 3 3-kinases
Four totally conserved motifs were found in the catalytic domain of all mammalian Ins(1,4,5)P 3 3-kinase isoforms (accession numbers P23677, Y18024 and AJ290975 for 3-kinases A, B and C respectively). These were also conserved in C. elegans (accession number P91166) but not in the InsP 6 kinases (accession number Q92551) or in the yeast protein ArgRIII (accession number NP-010458). Conserved residues are shown in bold. The dots are gaps introduced by the BESTFIT GCG program. ment with Ins(1,4,5)P $ 3-kinase A (i.e. PWKKLKTVLKYS$** ; Figure 2 , boxed residues) [15] .
Identification of a potential initiator codon
Part of the sequence of Ins(1,4,5)P $ 3-kinase C was also found in a screening of a mouse genomic library. The sequences of the first three exons of the mouse Ins(1,4,5)P $ 3-kinase C gene were obtained (results not shown). An alignment of the first exon of the mouse sequence (1137 bp) with the human sequence showed 64 % identity in terms of amino acids and 77 % in terms of nucleic acids ( Figure 3A) . In the human sequence, we have assigned the initiation codon to the ATG at position 29 ( Figure  3B , in bold) as it is flanked by a purine at position k3 and fits Kozak's criteria [34] . A PCR reaction on mouse uterus cDNA, using primers designed to hybridize within the first and third exons, confirmed that the first ATG is conserved and is preceded by an in-frame stop codon 61 bases upstream in the mouse sequence ( Figure 3B, underlined) . The putative starting methionine in the mouse cDNA is also flanked by a purine at position k3 and aligns with the human starting codon ( Figure 3B) .
A BLAST search in the protein domain database ProDom showed that the Ins(1,4,5)P $ 3-kinase C sequence contains a putative catalytic domain (domain PD010031), which is typical for Ins(1,4,5)P $ 3-kinase in mammalian and in Caenorhabditis elegans. The catalytic domain of Ins(1,4,5)P $ 3-kinase A was previously localized at the C-terminus and was restricted to a maximum of 275 amino acids [15] . An alignment of the corresponding catalytic domain of Ins(1,4,5)P $ 3-kinase C showed 73.2 % identity with 3-kinase A and 73.8 % identity with 3-kinase B. Mammalian Ins(1,4,5)P $ 3-kinases show four conserved motifs within the catalytic domain, which are 100 % conserved between the A, B and C isoforms, relatively well conserved in C. elegans but not with the InsP ' kinases or the yeast protein ArgRIII (Figure 4) .
Amino acid residues showing similarity to a segment of the Ins(1,4,5)P $ receptor [35] were also seen in the sequence of Ins(1,4,5)P $ 3-kinase C (i.e. LVKARERPRPR&!(). When compared with the sequences of the human genome database, we found a considerable number of 100 % identical partial clones which are localized on human chromosome 19. Northern-blot analysis of human Ins(1,4,5)P $ 3-kinase C expression showed the presence of a single transcript of approx. 3.9 kb in pancreas, Cloning of isoform C of inositol trisphosphate 3-kinase Figure 5 Tissue distribution of human Ins (1, 4, 5 
)P 3 3-kinase C
Northern-blot analysis of 2 µg of poly(A) + mRNA from various human tissues was hybridized with a catalytic probe of Ins(1,4,5)P 3 3-kinase C as described in the Materials and methods section. A single transcript of 3.9 kb is indicated by an arrow.
Table 1 Ins(1,4,5)P 3 3-kinase C activity in E. coli (DH5αFh) and COS-7 cells
Ins(1,4,5)P 3 3-kinase activity was determined in bacteria and in transfected COS-7 cells under basal conditions, i.e. in the presence of 1 mM EGTA or in the presence of 10 µM free Ca skeletal muscle, liver, lung, placenta and with a lower expression in kidney and brain ( Figure 5 ). The expression of the C isoform is therefore much more broadly expressed when compared with the A isoform, which is restricted to brain and testis [10] . On the other hand, this large distribution is comparable with that of the B isoform, which is expressed in rat lung, thymus, testis, brain and heart [10] .
Expression of Ins(1,4,5)P 3 3-kinase activity in DH5αFh bacteria
Ins(1,4,5)P $ 3-kinase C was subcloned into two different expression vectors (described in the Materials and methods section). The resulting plasmids were designated 3KS, which encoded a partial 3-kinase C sequence from amino acids 98-683 in the pBluescript vector, and VKC1, encoding the 683-amino-acid full-length sequence His-tagged in pTrc-His. Both constructs demonstrated Ins(1,4,5)P $ 3-kinase activity in bacteria, although crude lysates of the pBluescript construct had about 20-fold [23] .
Both of the recombinant enzymes (3KS and VKC1) expressed in DH5αFh bacteria were stimulated by Ca# + in the presence of calmodulin (2 µM). This degree of stimulation was much lower when compared with Ins(1,4,5)P $ 3-kinases A and B, and activity was only 1.5-fold greater than the basal activity when measured in the absence of the Ca# + -calmodulin complex (Table 1) , whereas recombinant 3-kinase A was typically stimulated 2-to 3-fold from basal levels [16] . The B isoform was stimulated more than 10-fold in the presence of Ca# + and calmodulin [9] .
Adsorption of recombinant Ins(1,4,5)P 3 3-kinase C on a calmodulin-Sepharose column
Mammalian Ins(1,4,5)P $ 3-kinases A and B could be purified by calmodulin-Sepharose affinity chromatography [16] , providing direct evidence of a calmodulin binding site. Since Ins(1,4,5)P $ 3-kinase C was poorly activated by Ca# + -calmodulin, we investigated if Ins(1,4,5)P $ 3-kinase C could be adsorbed on to the calmodulin-Sepharose matrix. We showed that the two bacterial Ins(1,4,5)P $ 3-kinase C constructs could be adsorbed on to this resin. An Ins(1,4,5)P $ 3-kinase antibody directed against a C-
Figure 7 Purification of the two recombinant Ins(1,4,5)P 3 3-kinase C constructs 3KS and VKC1 using calmodulin-Sepharose
A crude lysate of each construct was applied on to a calmodulin-Sepharose column. A sample of the crude extract and the fractions eluted with EGTA were analysed by Western blotting. (A) An Ins(1,4,5)P 3 3-kinase C antibody (dilution 1 : 100) was used for the 3KS construct and a single band at approx. 85 kDa was detected. (B) Purified material was separated by SDS/PAGE and the products were stained with blue colloid. Two major bands were found having a similar molecular mass (approx. 80-85 kDa). (C) A His 6 -tagged antibody (dilution 1 : 5000) for the VKC1 construct was used. A band at 105 kDa (indicated by an arrow) was revealed.
terminal peptide sequence of 3-kinase C recognized 3KS on a Western blot with an molecular mass of approx. 85 kDa ( Figure  7A ). No band was detected with a non-recombinant lysate (results not shown). A doublet with the same molecular mass was found on a blue-colloidal-stained gel ( Figure 7B ). MS analysis of the peptide fragments generated by trypsin treatment of these two bands showed that both corresponded to Ins(1,4,5)P $ 3-kinase C (D. Communi and V. Dewaste, unpublished work).
Western-blot analysis of the full-length active 3-kinase C (VKC1), purified by calmodulin-Sepharose chromatography, revealed a protein at 105 kDa after immunodetection with an anti-His ' antibody ( Figure 7C ), confirming the adsorption of 3-kinase C on calmodulin-Sepharose. We were aware of the large difference between the predicted and the apparent size of the protein on SDS gels, and the reason for this is not understood but it did not result from sequencing errors. This difference in size was also observed with the 3KS construct (65.0 kDa for the predicted size compared with 85 kDa for the apparent size on gels).
The apparent K m for Ins(1,4,5)P $ and V max values of 3KS were 6.4p0.9 µM and 2.1p0.1 µmol\min per mg of protein respectively (results not shown), which is comparable with the values obtained for Ins(1,4,5)P $ 3-kinases A and B when expressed in bacteria [9, 16, 32] .
Inhibition by calcium of Ins(1,4,5)P 3 3-kinase C activity expressed in COS-7 cells
The coding region of Ins(1,4,5)P $ 3-kinase C was subcloned into pcDNA3-His vector (described in the Materials and methods section) and expressed in COS-7 cells (COS3KC, Figure 1B) . As in DH5αFh bacteria, the activation of Ins(1,4,5)P $ 3-kinase C by Ca# + -calmodulin was rather weak and was only 20 % above the basal level (i.e. without Ca# + -calmodulin ; Table 1 ). In these transfected cells, Ca# + (10 µM) alone was shown to inhibit Ins(1,4,5)P $ 3-kinase C activity when compared with Ca# + -free solutions ( Figure 8A, upper panel) . This is in contrast with Ins(1,4,5)P $ 3-kinase A ( Figure 8A , lower panel) or 3-kinase B, where Ca# + alone had no effect on the kinase activity. This inhibitory effect on Ins(1,4,5)P $ 3-kinase C activity was also observed at lower calcium concentrations (0.1 and 1 µM ; Figure  8B ). This inhibition was reversed in the presence of calmodulin (2-20 µM ; Figure 8A , upper panel). An inhibitory effect of Ca# + at high concentrations (10 V ' to 10 V $ M free Ca# + ) has been reported in bovine brain inositol trisphosphate kinase after partial purification of the enzyme [14] . This could be related to the expression of Ins(1,4,5)P $ 3-kinase C in bovine brain. Western-blot analysis followed by immunodetection with an anti-His ' antibody of COS-7 cells transfected with Ins(1,4,5)P $ 3-kinase C also revealed a protein at 105 kDa ( Figure 9A, lane 2) . No activity could be detected in vector-transfected cells (Table  1) , and no signal in a Western blot was detected with this control ( Figure 9A, lane 1) . Activity determinations ( Figure 9C ) and Western-blot analysis ( Figure 9B ) revealed that 90 % of total Ins(1,4,5)P $ 3-kinase C activity was in the soluble fraction of transfected COS-7 cell homogenate.
Conclusions
We have isolated the cDNA of a novel Ins(1,4,5)P $ 3-kinase (isoform C). The unique feature of this enzyme was its relatively weak activation by the Ca# + -calmodulin complex, in contrast with the A and B isoforms, which are much more sensitive to the Ca# + -calmodulin complex [9, 16] . We have shown that Ins(1,4,5)P $ is phosphorylated specifically at the 3-position and thus the enzyme is also distinct from the yeast enzyme ArgRIII, which was shown to phosphorylate Ins(1,4,5)P $ at both the 3-and 6-carbons [22, 23] . This was related to key amino acid residues within the catalytic domain, which are present only in the mammalian Ins(1,4,5)P $ 3-kinase isoforms and the C. elegans isoforms. Indeed, an alignment of the amino acid sequences of the various 3-kinase isoforms shows the presence of four conserved motifs, and these are the potential sites which account for the reported specificity of the Ins(1,4,5)P $ 3-kinase reaction in mammalian cells (Figure 4 ). The Ins(1,4,5)P $ 3-kinases are also unrelated to the different mammalian InsP ' kinases, despite the presence of conserved residues in their catalytic domain, particularly in the Ins(1,4,5)P $ inositol polyphosphate binding site oas identified by site-directed mutagenesis of the Ins(1,4,5)P $ 3-kinase A isoform [31] q. The four conserved motifs were not seen in the sequence of InsP ' kinases ( Figure 4 ). In yeast, the Ins(1,4,5)P $ kinase activity of ArgRIII has been reported to empower a transcriptional complex with the ability to co-regulate a group of genes that control the utilization of Cloning of isoform C of inositol trisphosphate 3-kinase arginine as a nitrogen source [24] . The kinase is also compartmentalized in the nucleus of yeasts [24, 36] and Dictyostelium [37] . These findings naturally lead us to consider if transcriptional regulation may also be a function of mammalian 3-kinases. There are no indications in our studies that this might be a function for Ins(1,4,5)P $ 3-kinase C, which we identified to be a predominantly cytosolic enzyme with no defined nuclear targeting domains.
Theoretical studies have emphasized the potential importance of the activation of Ins(1,4,5)P $ 3-kinase activity by Ca# + in the control of calcium oscillations [38] . This model proposes that oscillations of Ins(1,4,5)P $ and Ins(1,3,4,5)P % are highly dependent upon the stimulation of Ins(1,4,5)P $ 3-kinase activity by Ca# + . The new data shown in the present study make it clear that Ins(1,4,5)P $ 3-kinase C is unlikely to play a major role in this process. In the 3-kinase C isoform, which was poorly activated by Ca# + and calmodulin, the ability to interact with a calmodulin-Sepharose matrix was nevertheless conserved, and this is therefore a common property of mammalian Ins(1,4,5)P $ 3-kinases.
However, one other possible role for the type C isoform of 3-kinase would be well served by its relative insensitivity to regulation by calcium and the apparent absence of consensus sites for phosphorylation by calmodulin kinase II. Recent studies have shown that one of the downstream metabolites of Ins(1,4,5)P $ , namely Ins(1,3,4)P $ , plays an important physiological role. Ins(1,3,4)P $ links the degree and duration of receptordependent phospholipase C activation to the generation of Ins(3,4,5,6)P % , a cellular signal that regulates the ionic conductance of Cl V channels [39] [40] [41] . The degree of precision with which these two signalling activities are coupled together depends upon how closely the levels of Ins(1,3,4)P $ mirror the rate of Ins(1,4,5)P $ synthesis by phospholipase C. This could be most efficiently achieved by a species of 3-kinase in which the activity was largely dependent upon substrate supply, rather than being sensitive to cross-talk from other signalling pathways. In the event that different isoforms of 3-kinase do turn out to play subtly different physiological roles, we might consider functional specificity to be further augmented by their regulated assembly into multimeric signalling complexes.
The cloning of Ins(1,4,5)P $ 3-kinase C adds to the repertoire of molecular tools by which the impact of changes in inositol trisphosphate 3-kinase activities upon cellular function can be studied. These tools will be important in the study of the regulation of expression of the corresponding gene in future studies in i o. 
